Amphastar Pharmaceuticals
AMPH
AMPH
134 hedge funds and large institutions have $478M invested in Amphastar Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 47 increasing their positions, 50 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 50
96% less call options, than puts
Call options by funds: $19K | Put options by funds: $496K
Holders
134
Holding in Top 10
–
Calls
$19K
Puts
$496K
Top Buyers
| 1 | +$11.7M | |
| 2 | +$8.2M | |
| 3 | +$7.83M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$5.7M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
+$4.58M |
Top Sellers
| 1 | -$5.38M | |
| 2 | -$3.97M | |
| 3 | -$3.43M | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$1.53M |
| 5 |
Canada Life
Winnipeg,
Manitoba, Canada
|
-$979K |